In mild COVID-19 patients' CD4 subset, Th EM-Tim-3+ (Median 3.3; Q1-Q3 2.45-5.6.3) population was significantly higher as compared to controls (Median 0.5; Q1-Q3 0.3-0.85; p=0.002). This evidence concerns the gene HAVCR2 and COVID-19.